Bcc Research Forecasts Chinese Market for Medical Polymers to Exceed $4 Billion by 2017
In the new report, the Chinese market for medical polymers was valued at $1.7 billion in 2011 and at $1.9 billion in 2012. The report forecasts total market value to surpass $4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 16.1%.
Wellesley, MA (PRWEB) July 19, 2013
In the new report, THE CHINESE MARKET FOR MEDICAL POLYMERS (Report code: PLS074A), from BCC Research (http://www.bccresearch.com), the Chinese market for medical polymers was valued at $1.7 billion in 2011 and at $1.9 billion in 2012. The report forecasts total market value to surpass $4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 16.1%.
The Chinese medical polymer market is growing quickly due to its close relationship with the pharmaceutical and medical device industries in China. The medical polymer market has grown steadily over the last twenty years and BCC Research predicts that this growth will continue over the next five years.
The Chinese medical polymer market is expected to be influenced by several factors such as the fast growth of the medical products market, establishment of pharmaceutical and medical device manufacturers in China, shifts by polymer manufacturers towards medical applications, production efficiency improvement, low emission standards and solutions for environmental constraints.
According the report, the cardiovascular market is the fastest growing market in terms of consumption of medical polymers, although it is currently one of the smallest markets. Additionally, the report states that PLA will be the fastest-growing segment over the next five years and it will grow at a CAGR of more than 26% from 2012 through 2017.
The research and development efforts for nontoxic polymers are increasing because of the high safety standards in the medical industry. The industry will also be significantly impacted by the increased environmental regulations in China. BCC Research has analyzed the impact of these new regulations and their impact on the medical polymer market specifically in this report.
BCC Research’s report discusses the three major segments of medical polymers: non-biodegradable medical resin and fibers, non-biodegradable medical elastomers, and biodegradable polymers. BCC Research has conducted a detailed valuation of the market for each of its segments, and has forecasted each segment’s growth over the next five years. The report segments the industry by region, product type, and market.
BCC Research then ranks each of these segments in terms of size and growth rate.
The medical polymers market and production centers are concentrated in five major regions in China, including the Yangtze River Delta, the Pearl River Delta, and Northern China. This report identifies the Yangtze River Delta as both the largest and fastest growing region for medical polymers in China.
The intended audience for this report includes medical polymer manufacturers and suppliers. Pharmaceutical companies, medical device manufacturers, and petrochemicals suppliers may also be interested in this report.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10932151.htm